Clinical Implications of Molecular Biomarkers
My Cancer Genome contains assertions on the clinical impact of
2,590 molecular biomarkers on
the use of 2,876 drugs in
957 cancer types. This
information is derived from FDA labels, NCCN and other professional
society guidelines, 9,852 clinical
trials, peer-reviewed publications, and more. Biomarker prevalence is
illustrated using data from
0 tumor samples and
89,356 patients in the AACR
Project GENIE database.
Learn About My Cancer Genome
